MDS Inc. Completes Divestiture of Central Labs Operations

TORONTO, Nov. 2 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a
leading provider of products and services to the global life sciences markets,
today announced that it has completed the divestiture of its Central Labs
operations to Czura Thornton, a private investment group based in Jersey,
Channel Islands.
Central Labs provides a comprehensive range of late-stage laboratory services
to global clients, including standardized assays, cardiac services, integrated
data management, international laboratory study co-ordination and site support
from 600 employees at six sites in Europe, North America and Asia.
"The completion of this transaction supports the Company's strategy to focus
on its MDS Nordion business," said Stephen P. DeFalco, President and Chief
Executive Officer of MDS Inc. "MDS Nordion remains committed to innovation and
operational excellence to further build its leadership positions in the
provision of medical isotopes for molecular and diagnostic imaging,
radiotherapeutics and sterilization technologies."

MDS Inc. Strategic Repositioning

On September 2, 2009, MDS announced it had reached an agreement with Danaher
Corporation to sell its MDS Analytical Technologies business. The Company also
announced that it intends to sell its remaining MDS Pharma Services business,
a leading provider of innovative drug discovery and early-stage development
solutions for pharmaceutical and biotechnology companies. Upon completion of
these transactions, the Company will be focused solely on its MDS Nordion
business, which is a leading provider of medical isotopes for molecular and
diagnostic imaging, radiotherapeutics and sterilization technologies.
Additional background materials pertaining to the new strategic direction for
MDS Inc. can be found on MDS Inc.'s Website at
http://www.mdsinc.com/strategic_repositioning_of_mds/index.asp.
There can be no assurance that MDS will complete a transaction involving MDS
Pharma Services. If MDS determines that there is not an acceptable
transaction, it intends to retain and invest in building the business.

About Czura Thornton

Czura Thornton is a private investment firm that has extensive experience in
international business, contract research and medical laboratories. The firm
is invested in the life sciences, property and transportation sectors. Further
information can be found at www.czurathornton.com.

About MDS

MDS Inc. (TSX: MDS; NYSE: MDZ) is a global life sciences company that provides
market-leading products and services that our customers need for the
development of drugs and diagnosis and treatment of disease. We are a leading
global provider of pharmaceutical contract research, medical isotopes for
molecular imaging, radiotherapeutics, and analytical instruments. MDS has more
than 3,600 highly skilled people in 13 countries. Find out more at
www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.

SOURCE MDS Inc.

MEDIA: Janet Ko, (905) 267-4226, janet.ko@mdsinc.com; INVESTORS: Peter Dans,
(905) 267-4230, peter.dans@mdsinc.com